סיפלוקס 500 ישראל - עברית - Ministry of Health

סיפלוקס 500

david margalit & co.ltd - ciprofloxacin as hydrochloride 500 mg - tablets - fluoroquinolones - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p.aeroginosa infections in pediatric patients aged 5-17 years.

ערמוניה ישראל - עברית - Ministry of Health

ערמוניה

unipharm trading ltd, israel - dutasteride - קפסולות רכות - dutasteride 0.5 mg - dutasteride

ערמוניה ישראל - עברית - Ministry of Health

ערמוניה

unipharm trading ltd, israel - dutasteride - קפסולות רכות - dutasteride 0.5 mg - dutasteride

SHILAV- ג'ל היגייני לידיים ישראל - עברית - Ministry of Health

shilav- ג'ל היגייני לידיים

א.ל. ארמן יצור תמרוקים בעמ - הגיינת הידיים

SHILAV - קרם הזנה לבטן לאחר לידה ישראל - עברית - Ministry of Health

shilav - קרם הזנה לבטן לאחר לידה

א.ל. ארמן יצור תמרוקים בעמ - הזנה לעור

SHILAV - קרם הזנה בתקופת ההריון ישראל - עברית - Ministry of Health

shilav - קרם הזנה בתקופת ההריון

א.ל. ארמן יצור תמרוקים בעמ - הזנה לעור

טרמפיה ישראל - עברית - Ministry of Health

טרמפיה

j-c health care ltd - guselkumab - תמיסה להזרקה - guselkumab 100 mg / 1 ml - guselkumab

אפרקס 1000 ישראל - עברית - Ministry of Health

אפרקס 1000

j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat

אפרקס 2000 ישראל - עברית - Ministry of Health

אפרקס 2000

j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 2000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat

אפרקס 4000 ישראל - עברית - Ministry of Health

אפרקס 4000

j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 4000 iu / 0.4 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat